TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28487141

Group type: EXPERIMENTAL
Intervention: One large beverage (750kcal drink with 55 E% from carbohydrates)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: One large beverage (750kcal drink with 20 E% from carbohydrates)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Five 150kcal portions every 30min (low-carbohydrate meals)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Five 150kcal portions every 30min
Number of subjects: 14
Study: 26112241

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) - 14 weeks, 3 sessions per week of four high-intensity cycling intervals
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (CON) - maintained normal level of physical activity
Number of subjects: 28
Study: 23086904

Group type: EXPERIMENTAL
Intervention: Fearful face presentation during the Stroop task
Number of subjects: 36

Group type: COMPARATOR
Intervention: Neutral face presentation during the Stroop task
Number of subjects: 36
Study: 21474494

Group type: EXPERIMENTAL
Intervention: Individual music therapy plus standard care (20 bi‐weekly sessions)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 79
Study: 18284437

Group type: EXPERIMENTAL
Intervention: PF‐00734200 (0.3 to 300 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: PF‐00734200 (10 mg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 16460875

Group type: EXPERIMENTAL
Intervention: Patient Perception of Bladder Condition (PPBC)
Number of subjects: 1385

Group type: EXPERIMENTAL
Intervention: Major PPBC improvement
Number of subjects: 1385
Study: 12600849

Group type: EXPERIMENTAL
Intervention: Frequent consumption of fresh juices (especially berry juices)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Preference for berry juice over other juices
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Consumption of fermented milk products ≥ 3 times/week
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Intercourse frequency ≥ 3 times/week
Number of subjects: 324
Study: 10839878

Group type: EXPERIMENTAL
Intervention: EMLA patch (5%‐1 g)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 9244418

Group type: EXPERIMENTAL
Intervention: CMV antigenemia assay
Number of subjects: 30

Group type: COMPARATOR
Intervention: Viral culture
Number of subjects: 30

Group type: COMPARATOR
Intervention: PCR
Number of subjects: 30

Group type: COMPARATOR
Intervention: Shell vial
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cytology
Number of subjects: 30
Study: 8401013

Group type: EXPERIMENTAL
Intervention: 15 mmol magnesium hydroxide daily for one year
Number of subjects: 468

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study: 3947901

Group type: EXPERIMENTAL
Intervention: Surgical drains
Number of subjects: 100

Group type: COMPARATOR
Intervention: No drainage (Control)
Number of subjects: 100
Study: 29376112

Group type: EXPERIMENTAL
Intervention: IVIG+ (Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy)
Number of subjects: 53

Group type: COMPARATOR
Intervention: NO-IVIG (No intravenous immunoglobulin with prednisone and risk-adapted chemotherapy)
Number of subjects: 53
Study: 27250658

Group type: EXPERIMENTAL
Intervention: Non-sedation supplemented with pain management during mechanical ventilation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sedation with a daily wake-up attempt
Number of subjects: 200
Study: 24788209

Group type: EXPERIMENTAL
Intervention: Spherical polyvinyl alcohol (SPVA) microspheres
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tris-acryl gelatin (TAG) microspheres
Number of subjects: 60
Study: 22206777

Group type: EXPERIMENTAL
Intervention: 1 mg/kg reslizumab
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: 2 mg/kg reslizumab
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: 3 mg/kg reslizumab
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study: 20452898

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI) therapy
Number of subjects: 249
Study: 17693107

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily
Number of subjects: 311

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 311
Study: 15948997

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg BIW
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg BIW
Number of subjects: 583

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg BIW (after dose reduction from 50 mg)
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg BIW (continuous)
Number of subjects: 583

Group type: COMPARATOR
Intervention: Placebo followed by etanercept 25 mg BIW
Number of subjects: 583
Study: 15189622

Group type: EXPERIMENTAL
Intervention: Implicit motive scores when motivational content was present in emotional memory
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit motive scores when motivational content was present in self-descriptive memory
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implicit motive scores for recalling specific agentic and communal events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit motive scores for recalling general achievement events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit motive scores for recalling general communal events
Number of subjects: 0
Study: 10225167

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 8.0% end-tidal concentration
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sevoflurane at 7.9% end-tidal concentration
Number of subjects: 64
Study: 8902255

Group type: EXPERIMENTAL
Intervention: Cyclandelate (1,200 mg daily for 12 weeks)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Propranolol (120 mg daily for 12 weeks)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Cyclandelate
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 214
Study: 1854763

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study: 6141089

Group type: EXPERIMENTAL
Intervention: Oxytocin induced labor
Number of subjects: 166

Group type: COMPARATOR
Intervention: Spontaneous labor
Number of subjects: 166
Study: 31440862

Group type: EXPERIMENTAL
Intervention: 1FOOT (one 60-min football session)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 3FOOT (three 60-min football sessions)
Number of subjects: 15
Study: 26267390

Group type: EXPERIMENTAL
Intervention: Family Check Up (FCU) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27460541

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg/day for 12 weeks
Number of subjects: 25
Study: 24607594

Group type: EXPERIMENTAL
Intervention: Cycle training (four sessions of 45 min)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control
Number of subjects: 94
Study: 22486894

Group type: EXPERIMENTAL
Intervention: Saline followed by 2% chlorhexidine gluconate (CHX)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 50% citric acid (CA) followed by 2% CHX
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 14% EDTA followed by 2% CHX
Number of subjects: 55

Group type: COMPARATOR
Intervention: Negative control (not specified)
Number of subjects: 55
Study: 20370923

Group type: EXPERIMENTAL
Intervention: Combination of surgery and trocar techniques (Group B)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Classical surgical technique (Group A)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Patients with TM (Group A)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Patients without TM (Group A)
Number of subjects: 180
Study: 17711710

Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban bolus (10 microg/kg) prior to the first balloon inflation (Group IC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous tirofiban bolus (10 microg/kg) prior to coronary angiography (Group IV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban (Group IC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous tirofiban (Group IV)
Number of subjects: 60
Study: 15386771

Group type: EXPERIMENTAL
Intervention: Knowledge of surveillance and/or preventative strategies for reduction of ovarian cancer risk
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Preference for screening as a risk management option
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Desire for information about ovarian cancer
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Preference for shared decision-making
Number of subjects: 129
Study: 12093600

Group type: EXPERIMENTAL
Intervention: Ipsapirone (0.3 mg/kg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 10367037

Group type: EXPERIMENTAL
Intervention: DXA scanner calibration shift during clinical trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard quality control procedures using phantoms
Number of subjects: 0
Study: 7551371

Group type: EXPERIMENTAL
Intervention: Zileuton (5-lipoxygenase inhibitor)
Number of subjects: 10
Study: 2165088

Group type: EXPERIMENTAL
Intervention: Clonidine (75 micrograms twice daily)
Number of subjects: 559

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Clonidine plus chlorthalidone (15 mg)
Number of subjects: 559

Group type: COMPARATOR
Intervention: Placebo plus chlorthalidone (15 mg)
Number of subjects: 559
Study: 91439

Group type: EXPERIMENTAL
Intervention: Five-drug combination chemotherapy program containing cis-dichlorodiammineplatinum(II)
Number of subjects: 25
Study: 31421669

Group type: EXPERIMENTAL
Intervention: Individualized, tablet-based physiotherapy training programme
Number of subjects: 0
Study: 29284686

Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Temazepam (10 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 26482910

Group type: EXPERIMENTAL
Intervention: OSU6162
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 23104129

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 239

Group type: COMPARATOR
Intervention: PCV7
Number of subjects: 239
Study: 21843222

Group type: EXPERIMENTAL
Intervention: Real-time automated feedback during chest compressions
Number of subjects: 0

Group type: COMPARATOR
Intervention: No feedback during chest compressions
Number of subjects: 0
Study: 19434566

Group type: EXPERIMENTAL
Intervention: STEPPS
Number of subjects: 79

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 79

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 79
Study: 16751033

Group type: EXPERIMENTAL
Intervention: 2 hours of daily patching with 1 hour of near visual activities
Number of subjects: 180

Group type: COMPARATOR
Intervention: Spectacles alone (if needed)
Number of subjects: 180
Study: 15289492

Group type: EXPERIMENTAL
Intervention: PC-SPES (3 capsules orally three times a day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diethylstilbestrol (DES, 3 mg orally once a day)
Number of subjects: 90
Study: 12451007

Group type: EXPERIMENTAL
Intervention: 500 mL of mineral water
Number of subjects: 13
Study: 9720812

Group type: EXPERIMENTAL
Intervention: Immunotherapy against birch pollen
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no immunotherapy)
Number of subjects: 24
Study: 7705114

Group type: EXPERIMENTAL
Intervention: Disposable barrier filter (Pall Biomedical, United Kingdom)
Number of subjects: 25
Study: 2784949

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 40
Study: 566734

Group type: EXPERIMENTAL
Intervention: Walking exercise
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Formal exercise regimens
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Exercise (general)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control programme
Number of subjects: 55
Study: 31872340

Group type: EXPERIMENTAL
Intervention: Exercise first (Group C)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Nutrition and exercise simultaneously (Group A)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Nutrition first (Group B)
Number of subjects: 88
Study: 31474410

Group type: EXPERIMENTAL
Intervention: 12+ months DAPT
Number of subjects: 12162

Group type: COMPARATOR
Intervention: 12 months DAPT
Number of subjects: 12162

Group type: EXPERIMENTAL
Intervention: 12+ months DAPT (high DAPT score)
Number of subjects: 12162

Group type: COMPARATOR
Intervention: 12 months DAPT (high DAPT score)
Number of subjects: 12162

Group type: EXPERIMENTAL
Intervention: 12+ months DAPT (low DAPT score)
Number of subjects: 12162

Group type: COMPARATOR
Intervention: 12 months DAPT (low DAPT score)
Number of subjects: 12162

Group type: EXPERIMENTAL
Intervention: Overall clinical events (MI + bleeding) 12+ months DAPT
Number of subjects: 12162

Group type: COMPARATOR
Intervention: Overall clinical events (MI + bleeding) 12 months DAPT
Number of subjects: 12162
Study: 27381040

Group type: EXPERIMENTAL
Intervention: Internet-based healthcare system for diabetes management for six months
Number of subjects: 484

Group type: COMPARATOR
Intervention: Usual outpatient management for six months
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Internet-based healthcare system for diabetes management for six months (subgroup with baseline HbA1c > 8%)
Number of subjects: 484
Study: 25814193

Group type: EXPERIMENTAL
Intervention: HVT to the atlanto-axial segment (n = 11)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Pre-manipulative hold position (Control group, n = 12)
Number of subjects: 23
Study: 23660210

Group type: EXPERIMENTAL
Intervention: SARS-related PTSD group (n = 18)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Convalescent SARS patients without PTSD (n = 26)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Normal control subjects (n = 18)
Number of subjects: 58
Study: 21123087

Group type: EXPERIMENTAL
Intervention: Education intervention (2-day workshop + written materials)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Written materials alone
Number of subjects: 185
Study: 19446205

Group type: EXPERIMENTAL
Intervention: Local anesthetic plus ketamine (LAK)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Local anesthetic alone (LAA)
Number of subjects: 50
Study: 17241499

Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physiologic saline infusion
Number of subjects: 60
Study: 15515877

Group type: EXPERIMENTAL
Intervention: Low-dose insulin regimen (1 IU/h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11527675

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (30 g/d)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 13
Study: 9764549

Group type: EXPERIMENTAL
Intervention: Erythromycin estolate at 40 mg/kg/day in two divided doses
Number of subjects: 302

Group type: COMPARATOR
Intervention: Amoxicillin at 50 mg/kg/day in two divided doses
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Erythromycin estolate
Number of subjects: 302

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 302
Study: 29460262

Group type: EXPERIMENTAL
Intervention: Calm voice stimuli
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Turbulent voice stimuli
Number of subjects: 20
Study: 28409379

Group type: EXPERIMENTAL
Intervention: Laparoscopic approach
Number of subjects: 14

Group type: COMPARATOR
Intervention: Open surgical approach
Number of subjects: 14
Study: 24836472

Group type: EXPERIMENTAL
Intervention: Double gloves with outer pair removed after verified intubation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Single gloves
Number of subjects: 41
Study: 22931923

Group type: EXPERIMENTAL
Intervention: Broadband light (BBL) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 19331437

Group type: EXPERIMENTAL
Intervention: Fenofibrate/ezetimibe
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fenofibrate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ezetimibe
Number of subjects: 60
Study: 17709798

Group type: EXPERIMENTAL
Intervention: Tamoxifen 1 mg/day
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg/week
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Tamoxifen 5 mg/day
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210

Group type: COMPARATOR
Intervention: Both placebos
Number of subjects: 210
Study: 15010407

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Esophageal Tracheal Combitube (ETC)
Number of subjects: 57
Study: 11587974

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Conservative Treatment (CT) - sleep hygiene and weight loss
Number of subjects: 142
Study: 9842079

Group type: EXPERIMENTAL
Intervention: Minimal Intervention (MI)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Advanced Intervention (AI)
Number of subjects: 54
Study: 7856197

Group type: EXPERIMENTAL
Intervention: Medical compression stockings (Thrombo+Sigvaris 503)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Short stretch bandages (Rosidal K)
Number of subjects: 50
Study: 2791799

Group type: EXPERIMENTAL
Intervention: Mealtime regimen (400 mg three times a day with meals)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Bedtime regimen (1200 mg at bedtime)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Reference regimen (200 mg three times a day with meals and 600 mg at bedtime)
Number of subjects: 141
Study: 338025

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (10 ml by intravenous infusion)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (29 patients)
Number of subjects: 59
Study: 31635844

Group type: EXPERIMENTAL
Intervention: 5% Sodium Hypochlorite (NaOCl)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 15.5% Ferric Sulfate (FS)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Indirect Pulp Therapy (IPT)
Number of subjects: 27
Study: 30945034

Group type: EXPERIMENTAL
Intervention: MC4R SNPs (rs17782313, rs633265, rs1350341, rs12970134)
Number of subjects: 927

Group type: EXPERIMENTAL
Intervention: GG genotype carriers of rs1350341
Number of subjects: 927
Study: 27250495

Group type: EXPERIMENTAL
Intervention: Marginally low Se-B (40-59 μg/l)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Optimal Se-B (≥80 μg/l)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Suboptimal Se-B (60-79 μg/l)
Number of subjects: 172

Group type: COMPARATOR
Intervention: All participants
Number of subjects: 172
Study: 25285989

Group type: EXPERIMENTAL
Intervention: Physical and psychosocial intervention program (12 weeks)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Non-participation
Number of subjects: 174

Group type: COMPARATOR
Intervention: Distance from home to hospital
Number of subjects: 174
Study: 23800438

Group type: EXPERIMENTAL
Intervention: Mental concentration (low stress condition)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mental concentration with psychosocial stress (high stress condition)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Baseline resting seated posture
Number of subjects: 60
Study: 21539106

Group type: EXPERIMENTAL
Intervention: Deep sclerectomy with angle dilatation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sinusotrabeculectomy (Control)
Number of subjects: 80
Study: 19321587

Group type: EXPERIMENTAL
Intervention: 80 mg/d of isoflavones
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: 120 mg/d of isoflavones
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study: 17589924

Group type: EXPERIMENTAL
Intervention: GeneVac-B
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Engerix B
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Shanvac B
Number of subjects: 158
Study: 15106685

Group type: EXPERIMENTAL
Intervention: 5 mg diazepam
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11166746

Group type: EXPERIMENTAL
Intervention: Joel-Cohen incision, one-layer locked uterine suture, no peritoneization
Number of subjects: 158

Group type: COMPARATOR
Intervention: Pfannenstiel incision, double layer closure of the uterus, visceral and parietal peritoneization
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 158
Study: 9750706

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (M) 30 mg.kg‐1 over 1 hour, followed by 5.4 mg.kg‐1.h‐1 for 23 hours
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Nimodipine (N) 0.015 mg.kg‐1.h‐1 over 2 hours followed by 0.03 mg.kg‐1.h‐1 for 7 days
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both M and N (MN)
Number of subjects: 106

Group type: COMPARATOR
Intervention: No medical treatment (P)
Number of subjects: 106
Study: 7831600

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock-wave lithotripsy (ESWL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mechanical lithotripsy (Control)
Number of subjects: 10
Study: 3417466

Group type: EXPERIMENTAL
Intervention: Listening to relaxation-type music
Number of subjects: 75

Group type: COMPARATOR
Intervention: White noise
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no music or white noise)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combined groups (music and white noise)
Number of subjects: 75
Study: 31099632

Group type: EXPERIMENTAL
Intervention: Experimental arm (new anticancer drugs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm (standard treatment)
Number of subjects: 0
Study: 27914033

Group type: EXPERIMENTAL
Intervention: L-carnitine 2 g/day plus simvastatin 20 mg/day
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo plus simvastatin 20 mg/day
Number of subjects: 58